DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Bioavailability and pharmacokinetics of desmopressin in elderly men.

Author(s): Hougaard C, Matthiesen TB, Rittig S, Djurhuus JC

Affiliation(s): International Enuresis Research Center, Skejby Hospital, University Hospital of Aarhus, Denmark.

Publication date & source: 1997, Scand J Urol Nephrol Suppl., 183:53-4.

Publication type: Clinical Trial; Randomized Controlled Trial

The bioavailability and pharmacokinetics of desmopressin (Minirin, DDAVP) have been studied in elderly males, aged between 55 and 75 years. In a four-way randomised study, subjects received a dose of desmopressin either intravenously (2 micrograms) or orally (200 micrograms) and either at 11 am or 10 pm. Daytime and night-time urine samples were collected both with and without desmopressin treatment. Intravenous doses of desmopressin were observed to have a longer duration of action than when the dose was given orally. These differences in efficacy may be attributable to differences in the bioavailability of desmopressin after intravenous or oral treatment.

Page last updated: 2006-01-31

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017